Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [ACTIVE] · [HEALTH]

2 clusters · 11 sources · 23 days · First seen 25 days ago · Last updated 2 days ago

Brazil HIV prevention technology incorporation

Overview

Brazil’s National Commission for the Incorporation of Technologies in the SUS (Conitec) has issued a preliminary favorable recommendation to include injectable cabotegravir in the Unified Health System (SUS).

This long-acting medication, which is administered every two months following initial doses, is intended to expand HIV prevention options rather than replace existing oral Pre-Exposure Prophylaxis (PrEP). The Ministry of Health intends to prioritize the injectable version for highly vulnerable individuals who encounter social or logistical barriers to the consistent use of oral PrEP. While the recommendation marks a step toward diversifying prevention strategies, specific timelines and definitive priority criteria for its availability within the public health system have not yet been established.

Entities

Ministry of Health · Sistema Único de Saúde · Lívia Almeida Dutra · Nutes · Ministério da Saúde

Timeline

2 days ago

[HEALTH] 2 sources
Brazil considers injectable HIV prevention for SUS
Brazil is considering the incorporation of injectable cabotegravir into the SUS to expand HIV prevention, prioritizing vulnerable populations who struggle to use oral PrEP.
25 days ago

[HEALTH] 9 sources
Brazil's SUS increases Natalizumab distribution for multiple sclerosis
A study by Einstein Hospital shows a 44.5% increase in Natalizumab distribution via Brazil's SUS from 2019 to 2023, following updated clinical guidelines for multiple sclerosis treatment.

Sources

acessa.com · chicoterra.com · chumbogrossomanaus.com.br · correiodecarajas.com.br · imprensapublica.com.br · jornale.com.br · jornalenoticias.com.br · mrnews.com.br · onortao.com.br · polemicaparaiba.com.br · tribunadaserra.com.br